atonic seizure - Nursing Case Study

Pathophysiology

• Primary mechanism: Atonic seizures occur due to sudden, temporary loss of muscle tone, often resulting from abnormal electrical discharges in the brain, particularly affecting the motor cortex. This disruption leads to transient interruptions in signals responsible for muscle contraction.

• Secondary mechanism: Dysfunctional inhibitory neuronal pathways, particularly those involving GABAergic neurotransmission, fail to adequately suppress excessive neuronal activity. This imbalance contributes to the sudden onset of muscle weakness or collapse.

• Key complication: The abrupt loss of muscle tone increases the risk of falls and injuries, posing significant safety concerns for individuals during atonic seizure episodes.

Patient Profile

Demographics:

28-year-old male, software engineer

History:

• Key past medical history: Diagnosed with epilepsy at age 24, history of migraine headaches

• Current medications: Lamotrigine 150 mg twice daily, Ibuprofen as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden episodes of muscle weakness and brief loss of consciousness

• Key symptoms: Frequent muscle twitching, confusion post-seizure, mild headache

• Vital signs: Blood pressure 145/92 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

As the healthcare team conducts an initial assessment, they note that the patient's episodes of sudden muscle weakness and brief loss of consciousness have increased in frequency over the past two weeks. A thorough neurological evaluation reveals persistent muscle twitching and postictal confusion, which lasts for approximately 30 minutes after each episode. His vital signs indicate mild hypertension with a blood pressure of 145/92 mmHg and a heart rate of 98 bpm, suggesting potential stress or a secondary effect of recurrent seizures. Despite the ongoing administration of Lamotrigine, the patient reports experiencing two or three atonic seizures daily, raising concerns about the efficacy of his current medication regimen.

In response to these findings, additional diagnostic tests are ordered. The results of a comprehensive metabolic panel return within normal limits, ruling out electrolyte imbalances as a contributing factor. However, the EEG reveals a pattern of generalized slow-wave activity interspersed with sharp waves, indicative of ongoing epileptiform disturbances. These findings support the need for a reevaluation of his seizure management plan. The patient's serum Lamotrigine levels are also assessed, and results show subtherapeutic concentrations, explaining the inadequate seizure control.

Given the increased frequency and severity of atonic seizures, the clinical team must exercise critical reasoning to adjust the patient's treatment plan. Considering the subtherapeutic Lamotrigine levels, there is a potential need for dosage adjustment or the introduction of an adjunctive antiepileptic drug. Additionally, the patient's elevated blood pressure and heart rate may necessitate lifestyle modifications or pharmacologic interventions to manage these parameters effectively. The team discusses these options with the patient, emphasizing the importance of medication adherence, fall prevention strategies, and regular follow-up appointments to monitor his response to the revised treatment plan. This approach aims to reduce seizure frequency and prevent further complications, ensuring the patient's safety and quality of life.

Section 2

A week after adjusting the patient's treatment plan, which included increasing the dosage of Lamotrigine and introducing Levetiracetam as an adjunctive therapy, the healthcare team conducts a follow-up assessment. The patient reports a reduction in the frequency of atonic seizures, experiencing only one episode in the last three days, suggesting a positive initial response to the new regimen. However, during the assessment, the patient mentions experiencing sporadic episodes of dizziness and blurred vision, raising concerns about potential side effects of the medication adjustment. The team also notes mild orthostatic hypotension during the examination, with blood pressure readings of 130/85 mmHg lying down and 115/75 mmHg upon standing, alongside a heart rate of 105 bpm. These findings necessitate further evaluation to determine if they are related to the medication changes or another underlying issue.

To explore these new symptoms, the healthcare team orders additional diagnostic tests, including a repeat serum Lamotrigine level and a complete blood count (CBC). The serum Lamotrigine level indicates therapeutic concentrations, confirming that the dosage adjustment has achieved the desired drug levels. However, the CBC reveals a mild leukopenia, which may be associated with the introduction of Levetiracetam. This warrants close monitoring to ensure the patient's immune system remains uncompromised and to evaluate the need for potential modifications to the current medication plan. Given these developments, the team discusses the importance of continued monitoring and possible future adjustments with the patient, emphasizing the need to report any further adverse effects promptly.

The new complications highlight the complexity of managing epilepsy with multiple drug regimens and the necessity for ongoing clinical reasoning to balance seizure control with medication side effect management. The healthcare team plans to maintain a close follow-up schedule to monitor both the effectiveness of the current treatment and the patient’s overall health, ensuring that any emerging complications are addressed promptly. This iterative process aims to optimize the patient's quality of life while minimizing risks associated with both his condition and its treatment.

Section 3

As the follow-up continues, the healthcare team notes a change in the patient's status during the next scheduled visit. The patient reports an increase in fatigue and occasional tremors, which seem to coincide with the timing of his medication doses. On examination, the patient's vital signs remain stable when lying down, with a blood pressure of 128/82 mmHg and a heart rate of 98 bpm. However, upon standing, the patient exhibits more pronounced orthostatic changes, with a blood pressure of 110/70 mmHg and a heart rate of 112 bpm. These findings suggest a potential exacerbation of orthostatic hypotension, possibly linked to the medication regimen or an emerging side effect profile.

To further evaluate these symptoms, the team decides to conduct a comprehensive metabolic panel (CMP) and an orthostatic vital signs test in a more controlled setting. The CMP results are within normal limits, ruling out significant electrolyte imbalances or kidney dysfunction as contributing factors. However, the orthostatic test confirms significant postural changes in blood pressure and heart rate, reinforcing the suspicion that the patient's current medications might be contributing to these symptoms.

The healthcare team discusses the need for a nuanced approach to managing the patient's therapy, balancing the benefits of seizure control against the potential side effects affecting his quality of life. They consider adjusting the dosage of Levetiracetam, given its temporal association with the onset of fatigue and tremors. Additionally, the team emphasizes lifestyle modifications, such as increased fluid and salt intake, and advises on slow positional changes to mitigate orthostatic symptoms. The patient is encouraged to maintain a symptom diary to provide further insights into the timing and triggers of these new complications, facilitating more informed clinical decisions in future consultations.

Section 4

Several weeks after the healthcare team adjusted the patient's medication regimen and implemented lifestyle recommendations, the patient returns for a follow-up visit. During this visit, the patient reports a slight reduction in fatigue and tremors, suggesting some initial positive response to the interventions. However, he now expresses concerns about experiencing occasional dizziness and a sense of imbalance, particularly in the mornings. These symptoms have been documented in the symptom diary, which reveals a pattern of increased episodes upon waking and after prolonged periods of sitting.

On examination, the patient's orthostatic vital signs still indicate significant changes, with a standing blood pressure of 108/68 mmHg and a heart rate of 115 bpm, suggesting persistent orthostatic hypotension. Neurological assessment reveals mild ataxia, which could be contributing to the patient's feelings of imbalance. These findings prompt the healthcare team to explore other medications or conditions that might be playing a role, as the current adjustments have not fully alleviated the symptoms.

The team decides to conduct a more detailed neurological evaluation, including an electroencephalogram (EEG) to assess for any changes in seizure activity that could correlate with the patient's symptoms. Additionally, a review of the patient's current medications is undertaken, considering possible interactions or cumulative side effects that might exacerbate orthostatic hypotension and ataxia. This comprehensive approach aims to refine the patient's management plan, ensuring optimal seizure control while minimizing adverse effects, thereby improving his overall quality of life.

Section 5

During the follow-up visit, the healthcare team receives the results of the electroencephalogram (EEG), which reveal sporadic bursts of abnormal brain activity consistent with atonic seizures. This finding suggests that while the current medication regimen has slightly improved certain symptoms, it has not fully controlled the seizure activity. Concurrently, the medication review highlights a potential interaction between the patient's anticonvulsant and an antihypertensive drug, which could be contributing to the orthostatic hypotension and dizziness. Notably, the patient's serum sodium level is found to be mildly reduced at 132 mmol/L, prompting consideration of hyponatremia as a contributing factor to the dizziness and imbalance.

In light of these findings, the healthcare team decides to adjust the patient's medication regimen further. They opt to taper the antihypertensive medication carefully while introducing a different anticonvulsant with a more favorable side effect profile regarding orthostatic changes. They also advise increasing dietary sodium intake slightly under close monitoring to address the mild hyponatremia. The patient's care plan is updated to include regular follow-up visits to monitor blood pressure, seizure frequency, and any further side effects. This refined approach aims to achieve better control of the atonic seizures while minimizing the risk of adverse effects, thereby enhancing the patient's stability and quality of life.